Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

203.00
-0.0200-0.01%
Post-market: 203.000.00000.00%16:35 EDT
Volume:588.40K
Turnover:119.62M
Market Cap:24.32B
PE:47.78
High:204.54
Open:203.20
Low:202.57
Close:203.02
52wk High:219.69
52wk Low:133.38
Shares:119.79M
Float Shares:119.32M
Volume Ratio:0.81
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.25
EPS(LYR):3.14
ROE:15.71%
ROA:7.59%
PB:6.92
PE(LYR):64.56

Loading ...

Press Release: Enlight Secures Nearly $340 Million in Tax Equity Partnerships for Roadrunner Solar and Energy Storage Project

Dow Jones
·
Sep 29

PTC India Financial Services Announces Resignation of Independent Directors

TIPRANKS
·
Sep 28

Hold Rating on PTC Therapeutics Amid Competitive Gene Therapy Landscape and High-Risk Outlook

TIPRANKS
·
Sep 24

PTC Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Sep 19

PTC Industries Arm Commissions Vacuum Arc Remelting Furnace for Large Titanium Castings

MT Newswires Live
·
Sep 18

New Buy Rating for PTC (PTC), the Technology Giant

TIPRANKS
·
Sep 16

PTC Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 12

PTC Inc. Stock Slides 4.1%, Underperforms Peers

Dow Jones
·
Sep 10

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment

Benzinga
·
Sep 09

Technical Indicators Generate Superior "Alpha" in China Compared to US, Particularly in Small-Cap Stocks

Deep News
·
Sep 05

PTC Therapeutics Price Target Maintained With a $118.00/Share by Cantor Fitzgerald

Dow Jones
·
Sep 03

PTC Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 28

PTC Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
Aug 23

PTC Therapeutics Stock Is Stuck In A Multi-Year Slump

Benzinga_recent_news
·
Aug 21

PTC Industries Wins INR1.1 Billion Order for Critical Titanium Castings

MT Newswires Live
·
Aug 21

PTC Industries Secures New Order Worth INR1 Billion

MT Newswires Live
·
Aug 21

PTC Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 21

PTC Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
Aug 20

PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns

Benzinga
·
Aug 19

PTC Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 19